NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks

Christopher C. Dvorak; Clarisa R. Gracia; Jean E. Sanders; Edward Y. Cheng; K. Scott Baker; Michael A. Pulsipher; Anna Petryk

doi:10.1016/j.bbmt.2011.10.006

NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks

Christopher C. Dvorak, Clarisa R. Gracia, Jean E. Sanders, Edward Y. Cheng, K. Scott Baker, Michael A. Pulsipher, Anna Petryk

Research output: Contribution to journal › Article › peer-review

80 Scopus citations

Abstract

The endocrine system is highly susceptible to damage by high-dose chemotherapy and/or irradiation before hematopoietic cell transplantation (HCT) during childhood. The specific endocrine organs most affected by HCT include the thyroid gland, the pituitary, and the gonads. In addition, hormones that support development and stability of the skeletal system are also affected. Insufficiency of thyroid hormone is 1 of the most common late sequelae of HCT, and occurs more often in young children. Deficiency in the pituitary's production of growth hormone is a problem of unique concern to the pediatric population. The reproductive risks of HCT depend on the patient's gender and pubertal status at the time of HCT. Pubertal or gonadal failure frequently occurs, especially in females. Infertility risks for both genders remain high, whereas methods of fertility preservation are limited in all but postpubertal males. Bone health post-HCT can be compromised by low bone mineral density as well as avascular necrosis, but the data on both problems in the pediatric HCT population are limited. In this paper, the current state of knowledge, gaps in that knowledge, and recommendations for future research are addressed in detail for each of these systems.

Original language	English (US)
Pages (from-to)	1725-1738
Number of pages	14
Journal	Biology of Blood and Marrow Transplantation
Volume	17
Issue number	12
DOIs	https://doi.org/10.1016/j.bbmt.2011.10.006
State	Published - Dec 2011

Bibliographical note

Funding Information:
Financial disclosure: C.C.D., A.P., J.S., and C.G. have nothing to disclose. E.Y.C. would like to disclose a limited financial relationship (<$5000) with Innomed and Biomet, and past research funding from Aastrom Biosciences.

Funding Information:
Funding for this work was made possible in part by the following National Institute of Health grants: 1R13CA159788-01 (M.P., K.S.B.), U01HL069254 (M.P.), R01 CA112530-05 (K.S.B.) . The views expressed in this manuscript do not reflect the official policies of the Department of Health and Human Services, nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Further support was provided by a generous grant from the St. Baldrick’s Foundation and the Lance Armstrong Foundation, as well as the following pharmaceutical companies: Genzyme, Otsuka America Pharmaceutical, Inc., and Sigma-Tau Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of those that provided funding. A.P. thanks Dr. Lynda Polgreen for her helpful comments.

Keywords

Growth failure
Infertility
Late effects
Pediatric allogeneic transplantation
Pediatric autologous transplantation
Thyroid dysfunction

Access

10.1016/j.bbmt.2011.10.006

OpenUrl availability

Full text

Fingerprint

Dive into the research topics of 'NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks'. Together they form a unique fingerprint.

Cite this

Dvorak, C. C., Gracia, C. R., Sanders, J. E., Cheng, E. Y., Scott Baker, K., Pulsipher, M. A., & Petryk, A. (2011). NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. Biology of Blood and Marrow Transplantation, 17(12), 1725-1738. https://doi.org/10.1016/j.bbmt.2011.10.006

NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. / Dvorak, Christopher C.; Gracia, Clarisa R.; Sanders, Jean E. et al.
In: Biology of Blood and Marrow Transplantation, Vol. 17, No. 12, 12.2011, p. 1725-1738.

Research output: Contribution to journal › Article › peer-review

Dvorak, CC, Gracia, CR, Sanders, JE, Cheng, EY, Scott Baker, K, Pulsipher, MA & Petryk, A 2011, 'NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks', Biology of Blood and Marrow Transplantation, vol. 17, no. 12, pp. 1725-1738. https://doi.org/10.1016/j.bbmt.2011.10.006

Dvorak CC, Gracia CR, Sanders JE, Cheng EY, Scott Baker K, Pulsipher MA et al. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. Biology of Blood and Marrow Transplantation. 2011 Dec;17(12):1725-1738. doi: 10.1016/j.bbmt.2011.10.006

Dvorak, Christopher C. ; Gracia, Clarisa R. ; Sanders, Jean E. et al. / NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation : Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. In: Biology of Blood and Marrow Transplantation. 2011 ; Vol. 17, No. 12. pp. 1725-1738.

@article{5db9f52e4ac04761ad288dbd6d67507d,

title = "NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks",

abstract = "The endocrine system is highly susceptible to damage by high-dose chemotherapy and/or irradiation before hematopoietic cell transplantation (HCT) during childhood. The specific endocrine organs most affected by HCT include the thyroid gland, the pituitary, and the gonads. In addition, hormones that support development and stability of the skeletal system are also affected. Insufficiency of thyroid hormone is 1 of the most common late sequelae of HCT, and occurs more often in young children. Deficiency in the pituitary's production of growth hormone is a problem of unique concern to the pediatric population. The reproductive risks of HCT depend on the patient's gender and pubertal status at the time of HCT. Pubertal or gonadal failure frequently occurs, especially in females. Infertility risks for both genders remain high, whereas methods of fertility preservation are limited in all but postpubertal males. Bone health post-HCT can be compromised by low bone mineral density as well as avascular necrosis, but the data on both problems in the pediatric HCT population are limited. In this paper, the current state of knowledge, gaps in that knowledge, and recommendations for future research are addressed in detail for each of these systems.",

keywords = "Growth failure, Infertility, Late effects, Pediatric allogeneic transplantation, Pediatric autologous transplantation, Thyroid dysfunction",

author = "Dvorak, {Christopher C.} and Gracia, {Clarisa R.} and Sanders, {Jean E.} and Cheng, {Edward Y.} and {Scott Baker}, K. and Pulsipher, {Michael A.} and Anna Petryk",

note = "Funding Information: Financial disclosure: C.C.D., A.P., J.S., and C.G. have nothing to disclose. E.Y.C. would like to disclose a limited financial relationship (<$5000) with Innomed and Biomet, and past research funding from Aastrom Biosciences. Funding Information: Funding for this work was made possible in part by the following National Institute of Health grants: 1R13CA159788-01 (M.P., K.S.B.), U01HL069254 (M.P.), R01 CA112530-05 (K.S.B.) . The views expressed in this manuscript do not reflect the official policies of the Department of Health and Human Services, nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Further support was provided by a generous grant from the St. Baldrick{\textquoteright}s Foundation and the Lance Armstrong Foundation, as well as the following pharmaceutical companies: Genzyme, Otsuka America Pharmaceutical, Inc., and Sigma-Tau Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of those that provided funding. A.P. thanks Dr. Lynda Polgreen for her helpful comments. ",

year = "2011",

month = dec,

doi = "10.1016/j.bbmt.2011.10.006",

language = "English (US)",

volume = "17",

pages = "1725--1738",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "Elsevier Inc.",

number = "12",

}

TY - JOUR

T1 - NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation

T2 - Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks

AU - Dvorak, Christopher C.

AU - Gracia, Clarisa R.

AU - Sanders, Jean E.

AU - Cheng, Edward Y.

AU - Scott Baker, K.

AU - Pulsipher, Michael A.

AU - Petryk, Anna

N1 - Funding Information: Financial disclosure: C.C.D., A.P., J.S., and C.G. have nothing to disclose. E.Y.C. would like to disclose a limited financial relationship (<$5000) with Innomed and Biomet, and past research funding from Aastrom Biosciences. Funding Information: Funding for this work was made possible in part by the following National Institute of Health grants: 1R13CA159788-01 (M.P., K.S.B.), U01HL069254 (M.P.), R01 CA112530-05 (K.S.B.) . The views expressed in this manuscript do not reflect the official policies of the Department of Health and Human Services, nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Further support was provided by a generous grant from the St. Baldrick’s Foundation and the Lance Armstrong Foundation, as well as the following pharmaceutical companies: Genzyme, Otsuka America Pharmaceutical, Inc., and Sigma-Tau Pharmaceuticals, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of those that provided funding. A.P. thanks Dr. Lynda Polgreen for her helpful comments.

PY - 2011/12

Y1 - 2011/12

N2 - The endocrine system is highly susceptible to damage by high-dose chemotherapy and/or irradiation before hematopoietic cell transplantation (HCT) during childhood. The specific endocrine organs most affected by HCT include the thyroid gland, the pituitary, and the gonads. In addition, hormones that support development and stability of the skeletal system are also affected. Insufficiency of thyroid hormone is 1 of the most common late sequelae of HCT, and occurs more often in young children. Deficiency in the pituitary's production of growth hormone is a problem of unique concern to the pediatric population. The reproductive risks of HCT depend on the patient's gender and pubertal status at the time of HCT. Pubertal or gonadal failure frequently occurs, especially in females. Infertility risks for both genders remain high, whereas methods of fertility preservation are limited in all but postpubertal males. Bone health post-HCT can be compromised by low bone mineral density as well as avascular necrosis, but the data on both problems in the pediatric HCT population are limited. In this paper, the current state of knowledge, gaps in that knowledge, and recommendations for future research are addressed in detail for each of these systems.

AB - The endocrine system is highly susceptible to damage by high-dose chemotherapy and/or irradiation before hematopoietic cell transplantation (HCT) during childhood. The specific endocrine organs most affected by HCT include the thyroid gland, the pituitary, and the gonads. In addition, hormones that support development and stability of the skeletal system are also affected. Insufficiency of thyroid hormone is 1 of the most common late sequelae of HCT, and occurs more often in young children. Deficiency in the pituitary's production of growth hormone is a problem of unique concern to the pediatric population. The reproductive risks of HCT depend on the patient's gender and pubertal status at the time of HCT. Pubertal or gonadal failure frequently occurs, especially in females. Infertility risks for both genders remain high, whereas methods of fertility preservation are limited in all but postpubertal males. Bone health post-HCT can be compromised by low bone mineral density as well as avascular necrosis, but the data on both problems in the pediatric HCT population are limited. In this paper, the current state of knowledge, gaps in that knowledge, and recommendations for future research are addressed in detail for each of these systems.

KW - Growth failure

KW - Infertility

KW - Late effects

KW - Pediatric allogeneic transplantation

KW - Pediatric autologous transplantation

KW - Thyroid dysfunction

UR - http://www.scopus.com/inward/record.url?scp=81255197717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255197717&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2011.10.006

DO - 10.1016/j.bbmt.2011.10.006

M3 - Article

C2 - 22005649

AN - SCOPUS:81255197717

SN - 1083-8791

VL - 17

SP - 1725

EP - 1738

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

IS - 12

ER -

NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: Endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this